The signatures identified in tumours from FANCI c.1813C>T carriers were compared to those exhibited by HGSC tumours, as there have been no reports attributing mutational signatures to cancers harbouring deleterious FANCI variants. This evidence concerns the gene FANCI and neoplasm.